KALA BIO stockholders elect three Class I directors, approve say-on-pay and auditor ratification

KALA BIO, Inc.

Marjan Farid, Andrew Koven, Gregory Perry elected as Class I directors for three-year terms.
Advisory vote on executive compensation approved with 764,305 votes for, 225,459 against.
Ratification of Deloitte & Touche LLP as auditor for FY2024 approved (1,825,140 for, 21,748 against).
Proposal to issue common stock upon conversion of Series E/F/G preferred stock approved (691,010 for, 49,921 against).
Three proposals to increase beneficial ownership limits on Series E/F/G preferred stock did not pass.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.